adenosine and ghk-cu micro-infusion system & Hyaluronic Acid GHK-cu Peptide, Advanced Micro-Needle Infusion Sys – PEPTIQ.skin adenosine & ghk-cu micro-infusion system

Control Release 232 , 6274 (2016)

After all, swelling in any area of the body changes the normal positioning of your tissues

It helps us protect the integrity of our work and the subjects of our research

The first component, cagrilintide , is a long-acting analogue of amylin a hormone co-secreted with insulin that acts at amylin and calcitonin receptors to promote satiety and slow gastric emptying

Semaglutide 2.4mg (GLP-1 Agonist): Proven GLP-1 effects (appetite suppression, gastric emptying) Already FDA-approved as Wegovy Established safety profile Cagrilintide 2.4mg (Amylin Analog): Mimics amylin, a hormone co-secreted with insulin Slows gastric emptying through different pathway than GLP-1 Reduces appetite through hindbrain (not hypothalamus) Improves postprandial glucose The Advantage: Leverages proven semaglutide efficacy and safety, adds complementary amylin effects